Abstract
The Pharmacogenomics Knowledge Base, PharmGKB, is an interactive tool for researchers investigating how genetic variation affects drug response. The PharmGKB Web site, http://www.pharmgkb.org, displays genotype, molecular, and clinical knowledge integrated into pathway representations and Very Important Pharmacogene (VIP) summaries with links to additional external resources. Users can search and browse the knowledgebase by genes, variants, drugs, diseases, and pathways. Registration is free to the entire research community, but subject to agreement to use for research purposes only and not to redistribute. Registered users can access and download data to aid in the design of future pharmacogenetics and pharmacogenomics studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
NIH. Goals for the PGRN. http://www.nigms.nih.gov/Research/FeaturedPrograms/PGRN/
Altman RB, Klein TE (2002) Challenges for biomedical informatics and pharmacogenomics. Annu Rev Pharmacol Toxicol 42:113–133
Povey S et al (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678–680
Wishart DS et al (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:D668–D672
Eichelbaum M et al (2009) New feature: pathways and important genes from PharmGKB. Pharmacogenet Genomics 19:403
Sangkuhl K et al (2008) PharmGKB: understanding the effects of individual genetic variants. Drug Metab Rev 40:539–551
Relling MV, Klein TE (2011) CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther 89:464–467
Swen JJ et al (2011) Pharmacogenetics: from bench to byte–an update of guidelines. Clin Pharmacol Ther 89:662–673
Bolton E, Wang Y, Thiessen PA, Bryant SH (2008) PubChem: integrated platform of small molecules and biological activities. In: Annual Reports in Computational Chemistry. American Chemical Society, Washington, DC
(US), N. L. o. M. MeSH Browser http://www.nlm.nih.gov/mesh/MBrowser.html
Organisation, I. H. T. S. D. SNOMED CT http://www.ihtsdo.org/snomed-ct/
Rubin DL et al (2005) A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge. J Am Med Inform Assoc 12:121–129
Altman RB et al (2003) Indexing pharmacogenetic knowledge on the World Wide Web. Pharmacogenetics 13:3–5
Garten Y, Altman RB (2009) Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text. BMC Bioinformatics 10(Suppl 2):S6
Coulet A et al (2010) Using text to build semantic networks for pharmacogenomics. J Biomed Inform 43:1009–1019
Chen J et al (2010) Interethnic comparisons of important pharmacology genes using SNP databases: potential application to drug regulatory assessments. Pharmacogenomics 11:1077–1094
Sissung TM et al (2010) Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform. Pharmacogenomics 11:89–103
Gamazon ER et al (2009) A pharmacogene database enhanced by the 1000 Genomes Project. Pharmacogenet Genomics 19:829–832
Feng J et al (2010) Compilation of a comprehensive gene panel for systematic assessment of genes that govern an individual’s drug responses. Pharmacogenomics 11:1403–1425
Demir E et al (2010) The BioPAX community standard for pathway data sharing. Nat Biotechnol 28:935–942
Desta Z et al (2009) Antiestrogen pathway (aromatase inhibitor). Pharmacogenet Genomics 19:554–555
Thorn CF, Klein TE, Altman RB (2009) Codeine and morphine pathway. Pharmacogenet Genomics 19:556–558
Yang J et al (2009) Etoposide pathway. Pharmacogenet Genomics 19:552–553
Marsh S et al (2009) Platinum pathway. Pharmacogenet Genomics 19:563–564
Sangkuhl K, Klein TE, Altman RB (2009) Selective serotonin reuptake inhibitors pathway. Pharmacogenet Genomics 19:907–909
Zaza G et al (2010) Thiopurine pathway. Pharmacogenet Genomics 20:573–574
Gong L, Altman RB, Klein TE (2011) Bisphosphonates pathway. Pharmacogenet Genomics 21:50–53
Maitland ML et al (2010) Vascular endothelial growth factor pathway. Pharmacogenet Genomics 20:346–349
Sangkuhl K, Klein TE, Altman RB (2010) Clopidogrel pathway. Pharmacogenet Genomics 20:463–465
Sangkuhl K et al (2011) Platelet aggregation pathway. Pharmacogenet Genomics 21(8):516–521
Oshiro C et al (2009) Taxane Pathway. Pharmacogenet Genomics 19:979–983
Mikkelsen TS et al (2011) PharmGKB summary: methotrexate pathway. Pharmacogenet Genomics 21(10):679–686
Sangkuhl K, Klein TE, Altman RB (2011) PharmGKB summary: citalopram pharmacokinetics pathway. Pharmacogenet Genomics 21(11):769–772
Thorn CF et al (2011) Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics 21(7):440–446
Thorn CF et al (2011) PharmGKB summary: fluoropyrimidine pathways. Pharmacogenet Genomics 21:237–242
Sim SC, Altman RB, Ingelman-Sundberg M (2011) Databases in the area of pharmacogenetics. Hum Mutat 32:526–531
Thorn CF, Klein TE, Altman RB (2010) Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics 11:501–505
Acknowledgments
The authors would like to acknowledge Dorit Berlin, Michelle Whirl Carrillo, John Conroy, Adrien Coulet, Sean David, Katrina Easton, Ray Fergerson, Yael Garten, Li Gong, Mei Gong, Winston Gor, Joan Hebert, Tina Hernandez-Boussard, Micheal Hewett, Amy Hodge, Laura Hodges, Daniel Holbert, Tiffany Jung, Mark Kiuchi, Steve Lin, Feng Liu, Xing Jian Lou, Charity Lu, Andrew MacBride, Ellen McDonagh, Diane Oliver, Connie Oshiro, Ryan Owen, Daniel Rubin, Katrin Sangkuhl, Farhad Shafa, Ravi Shankar, Rebecca Tang, TC Truong, Ryan Whaley, Mark Woon, and Tina Zhou for their contributions to building the PharmGKB.
The PharmGKB is financially supported by NIH/NIGMS (R24GM61374).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Thorn, C.F., Klein, T.E., Altman, R.B. (2013). PharmGKB: The Pharmacogenomics Knowledge Base. In: Innocenti, F., van Schaik, R. (eds) Pharmacogenomics. Methods in Molecular Biology, vol 1015. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-435-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-62703-435-7_20
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-434-0
Online ISBN: 978-1-62703-435-7
eBook Packages: Springer Protocols